Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 6 Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Colonic Neoplasms 4 Uterine Cervical Neoplasms 2 Neoplasm Metastasis 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Penile Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 Mouth Neoplasms 1 Locally Advanced Rectal Cancer (LARC) 1 Laryngeal Diseases 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1 dostarlimab 1 Tyrosine Kinase Inhibitors 1 Surveys and Questionnaires 1 Semen Analysis 1 Registries 1 Radiosurgery 1 Probiotics 1 Patient Reported Outcome Measures 1 Interviews as Topic 1 Folfox protocol 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms, Second Primary × dostarlimab × Clear all

NCT05855811 2024-07-15

PREDOSTAR

Centre Leon Berard

Phase 2 Recruiting

Neoplasms, Recurrence, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡